Assistant Professor, Department of Hematology & Oncology Pharmacy Mayo Clinic, Rochester, MN
For patients with advanced breast cancer, prognosis remains especially suboptimal, primarily because of acquired pharmacologic resistance. Fortunately, several new drugs and drug combinations have recently become available.
